Steve Bryson is a science writer for Myeloma Research News with a PhD in biochemistry. He covers the latest news and information on a variety of myeloma topics.| Rare Cancer News
Based on a clinical trial, the CAR T-cell therapy was approved for relapsed or refractory precursor B-cell acute lymphoblastic leukemia.| Rare Cancer News